MTIM
MRNA icon

Marathon Trading Investment Management’s Moderna MRNA Stock Holding History

Marathon Trading Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-203
Closed -$10.3K – 313
2026
Q1 		$10.3K Sell
203
-34,074
-99% -$1.59M ﹤0.01% 259
2025
Q4 		$1.01M Buy
+34,277
New +$931K 0.02% 145
2025
Q2 		– Sell
-1,880
Closed -$53.3K – 340
2025
Q1 		$53.3K Sell
1,880
-30,604
-94% -$1.09M 0.01% 297
2024
Q4 		$1.35M Buy
32,484
+23,565
+264% +$1.13M 0.07% 100
2024
Q3 		$596K Sell
8,919
-14,081
-61% -$1.29M 0.05% 131
2024
Q2 		$2.73M Buy
23,000
+6,570
+40% +$831K 0.21% 70
2024
Q1 		$1.75M Sell
16,430
-12,101
-42% -$1.22M 0.13% 89
2023
Q4 		$2.84M Buy
28,531
+21,531
+308% +$1.81M 0.14% 87
2023
Q3 		$723K Buy
7,000
+6,223
+801% +$694K 0.06% 131
2023
Q2 		$94.4K Buy
+777
New +$104K 0.01% 212
2021
Q1 		– Sell
-2,500
Closed -$261K – 469
2020
Q4 		$261K Buy
+2,500
New +$253K 0.01% 297

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Marathon Trading Investment Management's MRNA Position: Q2 2026 in Review

Marathon Trading Investment Management sold out of Moderna (MRNA) in Q2 2026, closing a stake of 203 shares — an estimated $10.3K sold.

Marathon Trading Investment Management first reported a position in MRNA in Q4 2020 and held it in 11 quarters. The position peaked at $2.84M in Q4 2023. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Marathon Trading Investment Management reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Marathon Trading Investment Management sold 203 Moderna shares in Q2 2026, an estimated $10.3K.
  • Marathon Trading Investment Management first reported a position in Moderna in Q4 2020 and held it in 11 quarters.
  • Marathon Trading Investment Management's Moderna position peaked at $2.84M in Q4 2023.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Marathon Trading Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.